Envista Holdings Corp (NVST)
19.80
+0.06
(+0.28%)
USD |
NYSE |
May 02, 16:00
19.80
0.00 (0.00%)
After-Hours: 20:00
Envista Holdings Research and Development Expense (Quarterly): 20.20M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 20.20M |
| September 30, 2023 | 22.30M |
| June 30, 2023 | 26.80M |
| March 31, 2023 | 24.50M |
| December 31, 2022 | 24.60M |
| September 30, 2022 | 26.00M |
| June 30, 2022 | 25.10M |
| March 31, 2022 | 24.40M |
| December 31, 2021 | 24.80M |
| September 30, 2021 | 24.00M |
| June 30, 2021 | 25.90M |
| March 31, 2021 | 25.80M |
| Date | Value |
|---|---|
| December 31, 2020 | 23.20M |
| September 30, 2020 | 20.00M |
| June 30, 2020 | 16.50M |
| March 31, 2020 | 34.70M |
| December 31, 2019 | 13.80M |
| September 30, 2019 | 36.30M |
| June 30, 2019 | 39.70M |
| March 31, 2019 | 43.30M |
| December 31, 2018 | 43.60M |
| September 30, 2018 | 42.30M |
| June 30, 2018 | 44.40M |
| March 31, 2018 | 41.70M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
13.80M
Minimum
Dec 2019
39.70M
Maximum
Jun 2019
25.19M
Average
24.60M
Median
Dec 2022
Research and Development Expense (Quarterly) Benchmarks
| Dentsply Sirona Inc | 43.00M |
| Biolase Inc | 1.652M |
| Milestone Scientific Inc | 0.1769M |
| Wellness Center USA Inc | -- |
| Sonendo Inc | 2.514M |